The latest price of fostatinib/fotantinib in 2025

The main function of fostamatinib is to inhibit the SYK signaling pathway through oral administration and reduce the destruction of platelets by the immune system, thereby increasing the number of platelets and reducing the risk of spontaneous bleeding and ecchymosis. This mechanism of action makes it an important drug in the treatment of chronic immune thrombocytopenia (ITP), especially in patients who have an inadequate response to glucocorticoids, immunoglobulins, or other conventional therapies. The oral administration mode facilitates long-term maintenance treatment, significantly improves patients' life convenience, and reduces the trouble of frequent hospital visits and intravenous infusions. Clinical practice shows that most patients can maintain stable platelet levels after taking fotantinib, and the drug is well tolerated.

In terms of price, the original drug of fotantinib has not yet been launched in mainland China, so the domestic price and medical insurance policy are still unclear. The overseas market is mainly dominated by the German original research version. The common specifications are 100 mg 60 tablets or 150 mg 60 tablets. Each box may be sold for between 20,000 and 40,000 yuan. The price is greatly affected by fluctuations in exchange rates and procurement channels. Compared with traditional domestic therapeutic drugs, the price of fotantinib is relatively high, but considering its convenience of oral administration and unique efficacy for refractory ITP, this price is still reasonable in the international market. It is worth noting that there are currently no imitation versions on the market in overseas markets, so accessibility is relatively limited.

With the accumulation of international treatment experience and the advancement of domestic drug registration processes, the accessibility and price strategy of fotantinib in the Chinese market may become clearer in the future. If it is launched in China and included in medical insurance negotiations, its price is expected to drop, allowing more patients to have access to long-term oral treatment. At the same time, patients should strictly follow the doctor's instructions during medication, and regularly monitor blood pressure, liver function and platelet levels to ensure maximum efficacy and controllable side effects. Scientific management will be the key guarantee for long-term efficacy and safety.

Reference materials:https://go.drugbank.com/drugs/DB12010